Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

STEMCELL Technologies Nilotinib, Size: 50 mg
SDP

Supplier:  STEMCELL Technologies 73304

Encompass_Preferred

Inhibit BCR/ABL and ABL with Nilotinib (Kitagawa et al. Genes Cells, 2013). This tyrosine kinase inhibitor binds to the ATP-binding pocket of ABL with higher affinity than imatinib (Manley et al. ASH Annu Meet Abstr, 2006). Nilotinib has various applications in cancer research, such as inhibiting cellular proliferation in many wild-type and mutant forms of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid leukemia (CML) cells (Verstovsek et al. Cancer, 2005; O’Hare, Cancer Res, 2005). Nilotinib is also used to inhibit cell proliferation and progression through S phase in human lung cell line A549 through transcriptional changes in DNA helicase complex, cyclins, and cyclin-dependent kinases (Ji et al. PLoS Comput Biol, 2009). Minocycline is supplied as a crystalline solid with ≥95% purity; Molecular weight 493.9 g/mol; CAS Number 641571-10-0. Visit STEMCELL.com for more information and related products.

Catalog No. 50-197-6057


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.